Clinical Study To Evaluate the efficacy of polyherbal Unani formulation in Zukam (Coryza OR Common Cold)

"TO EVALUATE THE EFFICACY AND SAFETY OF POLYHERBAL UNANI FORMULATIONS IN ZUKAM (CORYZA OR THE COMMON COLDE A RANDOMIZED STANDARD CONTROLLED CLINICAL TRIAL)" - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056975

Enrollment

Registered

2023-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J349- Unspecified disorder of nose and nasal sinuses

Interventions

Intervention1: Joshandha(Decoction) of bahidana unnab and Sapistan With Sharbate Banafsha 24ml for 7 days: Joshandha(Decoction) of Bahidana(Cydonia oblongata) 3gm, Unnab Zizyphus vulgaris 5no.(5-6gm)

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex in the age group of 18-60 years. Patient clinically diagnosed to be having uncomplicated Common cold. Patient who signs the consent paper and follow up protocol

Exclusion criteria

Exclusion criteria: Patient age below 18 year and more than 60-year male or female were excluded Patients with any complication of Common cold Common cold associated with any other systemic, metabolic or chronic disease • Mentally retarded patients • Patient malignancy of nose and throat • Patients not given consent

Design outcomes

Primary

Measure	Time frame
1. Reduction in Common cold Questionaire (CCQ) 2. Reduction in Visual Analogue Scale (VAS)Timepoint: 0,3 and 7th day	—

Secondary

Measure	Time frame
Reduction in symptomsTimepoint: 0, 3 & 7 day	—

Countries

India

Contacts

Public ContactDr Usamah Ahmad

State Unani medical College Prayagraj

asifhussainusmani@gmail.com7905831926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026